Peptonic Medical Clarifies DGH International AB Shareholding Acquisition

Peptonic Medical AB (publ) has issued clarifying information concerning its acquisition of a shareholding in DGH International AB, formerly Intellego Technologies AB. This follows a press release issued on September 2, 2026, at 07:00 CEST.

The company stated that its current business operations are not impacted by this acquisition and will continue as usual. The investment in DGH is intended to broaden Peptonic's exposure within the medical technology sector and to create conditions for long-term value creation through its stake in DGH.

Peptonic's Board of Directors has assessed that the strategic investment in DGH International AB presents significant opportunities for the company's development and expansion in the medical technology field. Further details regarding the specifics of the investment and its implications for Peptonic Medical's future strategy are anticipated.

The update aims to provide the market with a clearer understanding of the nature of the acquisition and its importance to Peptonic Medical's overall strategic direction.